Powered By ITDose InfoSystems Pvt. Ltd.
Barcode No. : M172163 Age / Sex : 28 YRS / Male
Patient NAME : Mr. PRAVEEN KUMAR
Sample Coll. DATE : 13-Sep-2022 06:59 PM Sample Receiving DATE : 13-Sep-2022 07:06 PM
UHID : 241434 Reporting DATE : 13-Sep-2022 07:40 PM
IPD No. / Ward : / Approved DATE : 13-Sep-2022 07:42 PM
Referring Doctor : Dr. CMO
Passport No. :
DEPARTMENT OF HAEMATOLOGY
Test Name Status Result Reference Range Unit
CBC (Complete Blood Count)* (Specimen : EDTA)
Haemoglobin 15.7 13.0-17.0 g/dl
(whole blood/photometric method)
Total Leucocyte Count (TLC) 4100 4000-10000 cells/cumm
(whole blood/impedence method)
Differential Leukocyte Counts -
Neutrophil H 70.8 45-70 %
Lymphocyte 25.2 20-40 %
Eosinophils L 0.7 1.0-5.0 %
Monocytes 2.6 2.0-10.0 %
Basophils 0.7 0.0-1.0 %
Packed Cell Volume (PCV) 46.6 40.0-50.0 %
Red Blood Cell Count 5.0 4.5-5.5 million/cumm
(whole blood/ impedence method)
Mean Cell Volume (MCV) 93.3 83.0-101.0 fl
(whole blood/calculated)
MCH 31.3 27.0-32.0 pg
(whole blood/calculated)
MCHC 33.6 31.5-34.5 g/dl
(whole blood/calculated)
RDW - CV 11.6 11.0-16.0 %
Platelet Count L 1.2 1.5-4.1 lakhs/cumm
(whole blood/impedence method)
MPV (Mean Platelet Volume) 10.0 6.5-12.0 fL
Interpretation :
CBC (Complete Blood Count)* : EDTA Whole Blood-Tests done on Automated Five PartnCell Counter.( Hb is performed by
photometric method,WBC,RBC,Platelet Count by impedence method,WBC differential by Flow Cytometry technology other
parameters calculated) All Abnormal Haemograms are reviewed confirmed microscopically.
These values are only indicative not confirmatory of diagnosis; Kindly correlate clinically.
(*) Test conducted under NABL scope MC-3302,Neo Hospital Laboratory, Noida.
Page 1 of 7
Powered By ITDose InfoSystems Pvt. Ltd.
Barcode No. : M172163 Age / Sex : 28 YRS / Male
Patient NAME : Mr. PRAVEEN KUMAR
Sample Coll. DATE : 13-Sep-2022 06:59 PM Sample Receiving DATE : 13-Sep-2022 07:06 PM
UHID : 241434 Reporting DATE : 13-Sep-2022 08:09 PM
IPD No. / Ward : / Approved DATE : 13-Sep-2022 08:12 PM
Referring Doctor : Dr. CMO
Passport No. :
DEPARTMENT OF SEROLOGY
Test Name Status Result Reference Range Unit
Malaria Antigen (Vivax and Falciparum Antigen) (Specimen : EDTA)
Malaria Antigen NEGATIVE -
Interpretation :
Malaria Antigen (Vivax and Falciparum Antigen) :
Summary:
· A visual, rapid qualitative and sensitive solid phase immunochromatographic assay based on antigen detection and is as an aid in the qualitative
diagnosis of infection. All positive samples are advised to be confirmed with microscopy.
· The possibility of resistant strain of malaria should always be considered, if the reaction of test remains positive with the same intensity after 5-10
days post treatment.
· Patient with rheumatoid factors, anti-nuclear antibody or dengue may give false positive results.
· The test can detect parasitemia levels of >=100 parasites/ µl of blood
These values are only indicative not confirmatory of diagnosis; Kindly correlate clinically.
(*) Test conducted under NABL scope MC-3302,Neo Hospital Laboratory, Noida.
Page 2 of 7
Powered By ITDose InfoSystems Pvt. Ltd.
Barcode No. : M172163 Age / Sex : 28 YRS / Male
Patient NAME : Mr. PRAVEEN KUMAR
Sample Coll. DATE : 13-Sep-2022 06:59 PM Sample Receiving DATE : 13-Sep-2022 07:06 PM
UHID : 241434 Reporting DATE : 13-Sep-2022 08:09 PM
IPD No. / Ward : / Approved DATE : 13-Sep-2022 08:12 PM
Referring Doctor : Dr. CMO
Passport No. :
DEPARTMENT OF SEROLOGY
Test Name Status Result Reference Range Unit
Typhidot (Typhoid IgG / IgM) (Specimen : EDTA)
TYPHIDOT IGG NEGATIVE -
TYPHIDOT IGM NEGATIVE -
Interpretation :
Typhidot (Typhoid IgG / IgM) :
Summary and Interpretation:-
· Rapid card test for qualitative detection of antibodies, to Salmonella typhi and Salmonella paratyphi in human serum or plasma.
· Negative result indicates absence of detectable amount of [Link] or paratyphi antibodies or antibodies not present during the stage of disease.
But this cannot exclude the possibility of infection.
· Some specimens containing unusually high titer or heterophile antibodies or rheumatoid factor may affect expected results.
· The results obtained with this test should only be interpreted in conjunction with other diagnostic procedure and clinical findings
IgM positive : Acute Enteric Fever
IgM & IgG positive : Persisting Enteric Fever (in the middle stage of infection)
IgG positive : Previous infection, relapse or re-infection. Clinical correlation required.
These values are only indicative not confirmatory of diagnosis; Kindly correlate clinically.
(*) Test conducted under NABL scope MC-3302,Neo Hospital Laboratory, Noida.
Page 3 of 7
Powered By ITDose InfoSystems Pvt. Ltd.
Barcode No. : M172163 Age / Sex : 28 YRS / Male
Patient NAME : Mr. PRAVEEN KUMAR
Sample Coll. DATE : 13-Sep-2022 06:59 PM Sample Receiving DATE : 13-Sep-2022 07:06 PM
UHID : 241434 Reporting DATE : 13-Sep-2022 09:40 PM
IPD No. / Ward : / Approved DATE : 13-Sep-2022 09:40 PM
Referring Doctor : Dr. CMO
Passport No. :
DEPARTMENT OF SEROLOGY
Test Name Status Result Reference Range Unit
DENGUE FEVER PROFILE (Specimen : SERUM)
Dengue Fever NS1 Antigen 94.42 <1.0(index value)-NEGATIVE: index value
>=1.0(index value) - POSITIVE
Dengue IgG Antibody 0.25 <1.0(index value)-NEGATIVE: index value
>=1.0(index value)- POSITIVE
Dengue IgM Antibody 1.95 <1.0(index value)-NEGATIVE: >=1.0 index value
(index value) : POSITIVE
Interpretation :
DENGUE FEVER PROFILE :
Method: Test performed with automated testing on ELFA technology (mini VIDAS/VIDAS) –
Interpretation of results in different stage of Infection :
Dengue infection VIDAS® DENGUE VIDAS® Anti-DENGUEVIDAS® Anti-
stage NS1 Ag IgM DENGUE IgG
Naive Négative Négative Négative
Acute infection Positive Positive Negative
Post-acute
Negative Positive Positive
infection
Recovery Negative Negative Positive
Notes:
Dengue virus (DENV) belongs to the Flaviviridae family and is transmitted to humans by Aedes mosquitoes. DENV are divided into four
serotypes: DEN-1, DEN-2, DEN-3 and DEN-4. The test detects all 4 serotypes.
Recommended test is NS1 Antigen in the first 5 days of fever. After 7-10 days of fever, the recommended test is Dengue fever
antibodies IgG & IgM.
Negative IgM result does not rule out Dengue infection. Additional sample to be tested after 7-14 days if infection is suspected, and if
positive Suggestive of Primary / Secondary Dengue infection.
Negative IgG indicates a presumptive evidence that the patient does not have secondary Dengue infection and if positive indicating
presumptive evidence that the patient has been recently exposed to / or currently infected with Dengue virus
In presence of detectable dengue NS1 antigen, Dengue IgG & IgM serology assays should be performed on follow up samples after 5-
7 days of onset of fever, to confirm dengue infection.
The disease may be subclinical, self limiting, febrile or may progress to a severe form of Dengue hemorrhagic fever or Dengue shock
syndrome.
Interference may be encountered with certain sera containing antibodies directed against reagent components. For this reason,
assay results should be interpreted taking into consideration the patient's clinical history and the results of any other tests
performed
References:
1. MULLER DA, DEPELSENAIRE ACI, YOUNG PR. Clinical and Laboratory Diagnosis of Dengue Virus Infection. J Infect Dis 2017;215:S89–
S95.
2. FRY SR, MEYER M, SEMPLE MG, et al. The Diagnostic Sensitivity of Dengue Rapid Test Assays Is Significantly Enhanced by Using a
These values are only indicative not confirmatory of diagnosis; Kindly correlate clinically.
(*) Test conducted under NABL scope MC-3302,Neo Hospital Laboratory, Noida.
Page 4 of 7
Barcode No. : M172163 Age / Sex : 28 YRS / Male
Patient NAME : Mr. PRAVEEN KUMAR
Sample Coll. DATE : 13-Sep-2022 06:59 PM Sample Receiving DATE : 13-Sep-2022 07:06 PM
UHID : 241434 Reporting DATE : 13-Sep-2022 09:40 PM
IPD No. / Ward : / Approved DATE : 13-Sep-2022 09:40 PM
Referring Doctor : Dr. CMO
Passport No. :
DEPARTMENT OF SEROLOGY
Test Name Status Result Reference Range Unit
Combined Antigen and Antibody Testing Approach. PLoS Negl Trop Dis 2011;5(6):e1199.
3. Testing Guidance. Dengue. CDC. 2019. Available at: [Link]
Accessed 4 June 2019.
These values are only indicative not confirmatory of diagnosis; Kindly correlate clinically.
(*) Test conducted under NABL scope MC-3302,Neo Hospital Laboratory, Noida.
Page 5 of 7
Powered By ITDose InfoSystems Pvt. Ltd.
Barcode No. : M172163 Age / Sex : 28 YRS / Male
Patient NAME : Mr. PRAVEEN KUMAR
Sample Coll. DATE : 13-Sep-2022 06:59 PM Sample Receiving DATE : 13-Sep-2022 07:06 PM
UHID : 241434 Reporting DATE : 13-Sep-2022 07:44 PM
IPD No. / Ward : / Approved DATE : 13-Sep-2022 07:45 PM
Referring Doctor : Dr. CMO
Passport No. :
DEPARTMENT OF BIOCHEMISTRY
Test Name Status Result Reference Range Unit
LFT (Liver Function Test) -Spectrophotometry* (Specimen : SERUM)
Bilirubin Total 0.9 0.0 - <1.0 mg/dl
(serum/azobilirubin/dyphylline)
Bilirubin Direct H 0.4 0.0-0.3 mg/dl
(serum/dual wavelength)
Bilirubin Indirect 0.5 0.0-1.1 mg/dl
(calculated)
Aspartate Transaminase (SGOT, AST) 42.0 17.0-59.0 U/l
(serum/kinetic withpyridoxal 5 phosphate/lactate
dehydrogenese)
SGPT, ALT (Alanine Transaminase) H 52.0 <50.0 U/L
(serum/kinetic with pyridoxal 5phosphate/lactate
dehydrogenase)
Alkaline Phosphatase (ALP) 63.0 38.0-126.0 U/L
(serum/4-nitrophenyl phosphate(pnpp)/amp)
Total Protein 7.0 6.3-8.2 gm/dl
(serum/biuret(alkaline cupric sulphate))
Albumin 4.9 3.5-5.0 gm/dl
(serum/bromocresol green dye binding)
Globulin (Calculated) 2.1 2.0-3.5 gm/dl
(calculated)
Albumin/Globulin Ratio (Calculated) H 2.4 0.8-1.1
(calculated)
GGT (Gamma Glutamyl Transpeptidase) 40.0 15.0-73.0 U/L
(serum/L-gamma-glumatyl-4-nitroanalide))
Interpretation :
LFT (Liver Function Test) -Spectrophotometry* : Note:
1. In an asymptomatic patient, Non alcoholic fatty liver disease (NAFLD) is the most common cause of increased AST, ALT levels. NAFLD is
considered as hepatic manifestation of metabolic syndrome.
2. In most type of liver disease, ALT activity is higher than that of AST; exception may be seen in Alcoholic Hepatitis, Hepatic Cirrhosis, and
Liver neoplasia. In a patient with Chronic liver disease, AST:ALT ratio>1 is highly suggestive of advanced liver fibrosis.
3. In known cases of Chronic Liver disease due to Viral Hepatitis B & C, Alcoholic liver disease or NAFLD, Enhanced liver fibrosis (ELF) test
may be used to evaluate liver fibrosis.
4. In a patient with Chronic Liver disease, AFP and Des-gamma carboxyprothrombin (DCP)/PIVKA II can be used to assess risk for
development of Hepatocellular Carcinoma.
KFT (Kidney Function Test)* (Specimen : SERUM)
Blood Urea 22.5 19.0-43.0 mg/dl
(urease with indicator dye)
Serum Creatinine 1.1 0.66-1.25 mg/dl
(enzymatic(creatinine amidohydrolase))
Uric Acid 7.9 3.5-8.5 mg/dl
These values are only indicative not confirmatory of diagnosis; Kindly correlate clinically.
(*) Test conducted under NABL scope MC-3302,Neo Hospital Laboratory, Noida.
Page 6 of 7
Barcode No. : M172163 Age / Sex : 28 YRS / Male
Patient NAME : Mr. PRAVEEN KUMAR
Sample Coll. DATE : 13-Sep-2022 06:59 PM Sample Receiving DATE : 13-Sep-2022 07:06 PM
UHID : 241434 Reporting DATE : 13-Sep-2022 07:44 PM
IPD No. / Ward : / Approved DATE : 13-Sep-2022 07:45 PM
Referring Doctor : Dr. CMO
Passport No. :
DEPARTMENT OF BIOCHEMISTRY
Test Name Status Result Reference Range Unit
(uricase/peroxidase)
Sodium (Na+) 140.0 137.0-145.0 mmol/L
(direct ion selective mode)
Potassium (K+) 3.8 3.5-5.1 mmol/L
(direct ion selective mode)
Chloride (Cl-) 99.0 98.0-107.0 mmol/L
(direct ion selective mode)
Serum Calcium 9.1 8.4-10.2 mg/dl
(arsenazo dye)
Phosphorus Serum 2.9 2.5-4.5 mg/dl
(phosphomolybdate reduction)
Alkaline Phosphatase (ALP) 63.0 38.0-126.0 U/L
(4-nitrophenyl phosphate(pnpp)/amp)
Total protein 7.0 6.3-8.2 gm/dl
(biuret(alkaline cupric sulphate))
Albumin 4.9 3.5-5.0 gm/dl
(bromocresol green dye binding)
Globulin (Calculated) 2.1 2.0-3.5 gm/dl
(calculated)
Albumin/Globulin Ratio (Calculated) H 2.4 0.8-1.1
(calculated)
eGFR 79.7 - mL/min
(calculated)
Interpretation :
KFT (Kidney Function Test)* :
*** End Of Report ***
These values are only indicative not confirmatory of diagnosis; Kindly correlate clinically.
(*) Test conducted under NABL scope MC-3302,Neo Hospital Laboratory, Noida.
Page 7 of 7